Wetzel Investment Advisors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-868
Closed -$120K 328
2024
Q2
$120K Sell
868
-15
-2% -$1.9K 0.07% 156
2024
Q1
$119K Buy
883
+857
+3,296% +$108K 0.07% 164
2023
Q4
$3K Buy
+26
New +$2.66K ﹤0.01% 776

Other funds holding DXCM

Wetzel Investment Advisors's DXCM Position: Q3 2024 in Review

Wetzel Investment Advisors sold out of DexCom (DXCM) in Q3 2024, closing a stake of 868 shares — an estimated $120K sold.

Wetzel Investment Advisors first reported a position in DXCM in Q4 2023 and held it in 3 quarters. The position peaked at $120K in Q2 2024. 889 funds tracked by Wall St. Rank hold DXCM as of Q3 2024.

  • Wetzel Investment Advisors reported no remaining DexCom position as of Q3 2024 after selling out during the quarter.
  • Wetzel Investment Advisors sold 868 DexCom shares in Q3 2024, an estimated $120K.
  • Wetzel Investment Advisors first reported a position in DexCom in Q4 2023 and held it in 3 quarters.
  • Wetzel Investment Advisors's DexCom position peaked at $120K in Q2 2024.
  • 889 funds tracked by Wall St. Rank held DexCom as of Q3 2024.

Based on Wetzel Investment Advisors's 13F filing for Q3 2024, filed 29 Oct 2024.